DEPLOYDatabase

Robot model

Garmin (Venu / Fenix / Forerunner)

Garmin (NASDAQ: GRMN; founded 1989 by Gary Burrell and Min Kao) makes biometric-primary multisport watches such as the Venu 3, Fenix 8, and Forerunner 965 with…

Track Garmin (Venu / Fenix / Forerunner)
Manufacturer
Garmin
Form factor
biometric
Maturity
commercial
Lifecycle
active
Deployments
1
Website
garmin.com ↗

Overview

Garmin (NASDAQ: GRMN; founded 1989 by Gary Burrell and Min Kao) makes biometric-primary multisport watches such as the Venu 3, Fenix 8, and Forerunner 965 with AI augmentation, recorded in the new biometric form factor. Its devices carry optical heart-rate, blood-oxygen, ECG on select models, and skin-temperature sensors, and layer proprietary analytics including Body Battery, Training Load and Training Readiness, advanced sleep tracking with a Sleep Score and coach, all-day stress, and HRV Status. Its one FDA clearance is the ECG App, cleared via 510(k) K221774 with a decision dated January 12, 2023 and launched on January 24, 2023 on the Venu 2 Plus as Garmin's first FDA-cleared feature for on-demand assessment of signs of atrial fibrillation, later expanded by software to other models. A cap-flag applies because most of Garmin's analytics, including blood oxygen, Body Battery, Training Readiness, stress, and Sleep Score, are wellness features rather than FDA-cleared, with Body Battery in particular a proprietary composite rather than a validated clinical metric, making Garmin lighter on FDA-cleared clinical AI than Apple or Fitbit. Garmin is the purchase-only outlier of the cohort: all core health and training features are free with no required membership, and the newer Garmin Connect+ subscription launched March 27, 2025 at $6.99 a month is optional, adding AI Active Intelligence insights and coaching content without gating existing features, in contrast to subscription-only Whoop and membership-required Oura. Its clinical-validation posture is lighter on cleared clinical AI with strong sensor hardware but proprietary, largely non-peer-validated recovery and training metrics, and the accuracy of Body Battery and Training Readiness and any 2026-model specifics are not verified.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Verified deployments
1 deployment on file
Sources on file
4 sources, view all

Key facts

FDA clearance

ECG App: FDA 510(k) K221774, decision Jan 12 2023, launched Jan 24 2023 on Venu 2 Plus

Sensor suite

Elevate optical HR, Pulse Ox (SpO2), ECG (select models), skin temp

Price

Garmin Connect+ optional subscription $6.99/mo or $69.99/yr, launched Mar 27 2025

Autonomy level

Purchase-only; all core health/training features free, no required membership

Models

Venu 3, Fenix 8, Forerunner 965, epix Pro, tactix

Specs

Notes

FDA clearances: ECG App: FDA 510(k) K221774, decision Jan 12 2023, launched Jan 24 2023 on the Venu 2 Plus (Garmin's first FDA-cleared feature; on-demand 30-sec ECG for signs of AFib). Later expanded by software to epix Pro, Fenix 7 Pro, Venu 3, Fenix 8., CAP-FLAG (most of Garmin's AI is wellness): Pulse Ox/SpO2, Body Battery, Training Readiness, stress, Sleep Score are WELLNESS features, NOT FDA-cleared. Body Battery in particular is a proprietary composite, not a validated clinical metric. Garmin is lighter on FDA-cleared clinical AI than Apple/Fitbit (one cleared feature: ECG)., Model framing (the purchase-only outlier): Garmin is fundamentally PURCHASE-ONLY: all core health/training features are free, no required membership. The newer Garmin Connect+ ($6.99/mo or $69.99/yr, launched Mar 27 2025) is OPTIONAL and adds AI 'Active Intelligence' insights + coaching content; it does NOT gate existing features. The outlier vs Whoop (subscription-only) / Oura (required membership)., Verification posture: Boundary: biometric-primary + AI-augmented. Clinical posture: lighter on FDA-cleared clinical AI (one cleared feature); strong SENSOR hardware but recovery/training metrics are proprietary, largely NOT peer-validated as clinical instruments. NOT verified: Body Battery / Training Readiness accuracy (proprietary, no clearance); 2026-model specifics.

Specs

Venu 3, Fenix 8, Forerunner 965 (+ epix Pro, tactix). Sensors: Elevate optical HR, Pulse Ox (SpO2), ECG (select models), skin temp. AI/health: Body Battery (energy/recovery proxy), Training Load / Training Readiness / recovery-time, advanced sleep + Sleep Score + sleep coach, all-day stress (HRV), HRV Status, Morning Report. Founded 1989 (NASDAQ: GRMN). PURCHASE-ONLY; optional Garmin Connect+ AI subscription ($6.99/mo, Mar 2025) does NOT gate existing features.

Battery

24 days

Weight kg

0.07

Form Factor

biometric (biometric-primary multisport watch + AI augmentation; ECG cleared, rest wellness)

Fda clearance

Source: garmin.com Status: none; Details: No FDA clearance. ECG available on select models (Venu 2 Plus, Fenix 7 Pro) but NOT FDA-cleared. Wellness/fitness positioning only.; Audited at: 2026-06-07; Source name: Garmin; Health claim: Fitness, outdoor, aviation. Wellness-only; ECG feature exists but lacks FDA clearance for arrhythmia detection.; Verification posture: verified

Data & sources

Press releases

1

Government records

1

Web sources

2

4 sources backing this record.View all →

Availability and pricing

Availability
Shipping now
Price
$849 to $2K (actual sale price)as of 2024-08-14
Units in field
Not disclosed
Sales model
Not disclosed
Lead time
Not disclosed

Pricing

One-time purchase

$849 - $1,699 USDactual sale priceas of 2024-08-14

Source: Garmin Fenix 8 launched Aug 2024; standard 51mm from $849.99; Pro MicroLED $1,699 (after $300 permanent price cut from $1,999 launch)

History

Price status: actual-sale-price = real published price at time of sale; manufacturer-target = vendor target, not yet realized; analyst-estimate = third-party projection, not a vendor figure; not-announced = no price on record.

Prices verified as of Aug 14, 2024

Deployments (1)

Garmin (Venu / Fenix / Forerunner) on the deployment map

Where Garmin (Venu / Fenix / Forerunner) is verified operating. Explore the deployment map by place and type.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Deployment-verified media (1)

PRIMARY SOURCE
Courtesy of Garmin

Garmin's reveal of its Fenix 8 flagship multisport smartwatch. The Fenix line is sports- and wellness-grade: Garmin's FDA-cleared ECG app is a Venu-line feature, not on the Fenix, so this carries no ECG or medical claim.

From deployment: Global

Regulatory filings (2)

Safety record

No incidents on record for Garmin (Venu / Fenix / Forerunner).

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (4)

  1. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K221774
  2. https://www.garmin.com/en-US/newsroom/press-release/wellness/garmin-ecg-app/
  3. https://www.garmin.com/en-US/newsroom/press-release/2025/garmin-connect-plus/
  4. https://www.garmin.com/en-US/blog/general/which-garmin-smartwatch-is-right-for-me/

Compare Garmin (Venu / Fenix / Forerunner)

Common questions

What is Garmin (Venu / Fenix / Forerunner)?
Garmin (NASDAQ: GRMN; founded 1989 by Gary Burrell and Min Kao) makes biometric-primary multisport watches such as the Venu 3, Fenix 8, and Forerunner 965 with AI augmentation, recorded in the new biometric form factor. Its devices carry optical heart-rate, blood-oxygen, ECG on select models, and skin-temperature sensors, and layer proprietary analytics including Body Battery, Training Load and Training Readiness, advanced sleep tracking with a Sleep Score and coach, all-day stress, and HRV Status. Its one FDA clearance is the ECG App, cleared via 510(k) K221774 with a decision dated January 12, 2023 and launched on January 24, 2023 on the Venu 2 Plus as Garmin's first FDA-cleared feature for on-demand assessment of signs of atrial fibrillation, later expanded by software to other models. A cap-flag applies because most of Garmin's analytics, including blood oxygen, Body Battery, Training Readiness, stress, and Sleep Score, are wellness features rather than FDA-cleared, with Body Battery in particular a proprietary composite rather than a validated clinical metric, making Garmin lighter on FDA-cleared clinical AI than Apple or Fitbit. Garmin is the purchase-only outlier of the cohort: all core health and training features are free with no required membership, and the newer Garmin Connect+ subscription launched March 27, 2025 at $6.99 a month is optional, adding AI Active Intelligence insights and coaching content without gating existing features, in contrast to subscription-only Whoop and membership-required Oura. Its clinical-validation posture is lighter on cleared clinical AI with strong sensor hardware but proprietary, largely non-peer-validated recovery and training metrics, and the accuracy of Body Battery and Training Readiness and any 2026-model specifics are not verified.
How much does Garmin (Venu / Fenix / Forerunner) cost?
Garmin (Venu / Fenix / Forerunner) is listed at $849 to $1,699 on the DEPLOY registry. This is an actual sale price on record.
Garmin Fenix 8 launched Aug 2024; standard 51mm from $849.99; Pro MicroLED $1,699 (after $300 permanent price cut from $1,999 launch)
Is Garmin (Venu / Fenix / Forerunner) actually deployed in the real world?
Yes. Garmin (Venu / Fenix / Forerunner) is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Is Garmin (Venu / Fenix / Forerunner) autonomous or teleoperated?
Partly. DEPLOY verifies Garmin (Venu / Fenix / Forerunner) operating autonomously for Tracks fitness and activity and Tracks sleep. Other capabilities (Tracks heart health and Tracks stress and recovery) are only demonstrated under teleoperation or remain vendor claims, not independently verified as autonomous.
What are the specs of Garmin (Venu / Fenix / Forerunner)?
Garmin (Venu / Fenix / Forerunner)'s recorded specifications on the DEPLOY registry: Battery: 24 days; Weight: 0.07 kg. See the Specs section for the full sourced set.
Methodology: Verified · 4 sources (2 primary) · last reviewed 2026-07-15

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-07-15

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: biometric

Sources by quality tier

2
unclassified
Unclassified source
1
primary-fda-database
FDA database
1
primary-company-ir
Company IR disclosure

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Garmin (Venu / Fenix / Forerunner).